フォローフィードコミュニティでトレーダーや投資家とつながりましょう.
包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.
ターミナル モニターで株式と資産のウォッチリストを整理および監視します
RARITAN, N.J., May 16, 2022 (GLOBE NEWSWIRE) -- Ortho Clinical Diagnostics Holdings plc (NASDAQ: OCDX...
0001828443Q1--01-02false0001828443us-gaap:CommonStockMember2021-04-040001828443us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMemberus-gaap:For...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K ...
Event Type: Q1 2022 Earnings Call Date: 2022-05-04 Company: Quidel Corp. Ticker: QDEL COMPANY PARTICIPANTS Ruben Argueta - Quidel Corp...
Filed by Quidel CorporationPursuant to Rule 425 under theSecurities Act of 1933, as amended,and deemed filed pursuant to Rule 14a-12of the...
Highlights • Core revenue declined (0.9%) to $495.0 million, and grew 0.6% in constant currency and 4.2...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549...
RARITAN, N.J., April 20, 2022 (GLOBE NEWSWIRE) -- Ortho Clinical Diagnostics Holdings plc (Nasdaq: OCDX), one...
FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...
Kuznicki Law PLLC is investigating the proposed sale of Ortho Clinical Diagnostics Holdings plc (NasdaqGS: OCDX) to Quidel Corporation (NasdaqGS:...
RARITAN, N.J., March 09, 2022 (GLOBE NEWSWIRE) -- Ortho Clinical Diagnostics (Nasdaq: OCDX), one of the world's largest pure-play in vitro...
Event Type: Q4 2021 Earnings Call Date: 2022-02-17 Company: Quidel Corp. Ticker: QDEL COMPANY PARTICIPANTS Ruben Argueta - Quidel Corp...
Highlights • Fourth quarter Core revenue grew 3.5% to $518.9 million, or 4.3% in constant currency and 8.0% excluding CoV-2 assay sales • Fiscal...
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約